Xeris Biopharma (XERS)

Xeris Biopharma (XERS) stock research: performance, analysts' price targets, earnings, revenue and margins, technicals and insider trades.

• XERS last traded at $10.13, -5.42% on the day.
• Xeris Biopharma: market cap $1.95B, P/E -104.7, revenue $335.41M over the last four quarters, next earnings 2026-11-05.
• Over the past year XERS returned 4.33%; year to date 29.04%.

Updated 2026-11-02 23:10 UTC